Back

Piramal and NP2 to complete cyclophosphamide development in October

Verifying
  • Piramal Pharma Solutions and NP2 plan to complete cyclophosphamide development in October 2026.
  • 92% of U.S. cyclophosphamide sales come from the two largest overseas manufacturers.
  • NP2 expects its ready-to-use injectable to reach the market in mid-2028.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.